Merck

MRK · NYSE · USD

$144.30+0.34%+$0.49

Close · October 2, 2026

At a glance

Revenue growth: +1.31%; 2025 vs 2024
Net income growth: +6.64%; 2025 vs 2024
Net margin: 28.1%; 2024: 26.7%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	16,607	16,286	16,400	17,276	15,806	15,529	15,624	16,657	16,112	15,775	14,630	15,962
Cost of revenue	4,128	3,875	4,295	3,745	3,392	3,383	3,707	3,888	3,679	3,424	3,795	4,231
Gross profit	12,479	12,411	12,105	13,531	12,414	12,146	11,917	12,769	12,433	12,351	10,835	11,731
Selling, general and administrative	2,777	2,566	2,733	2,481	2,496	2,404	2,691	2,543	2,549	2,318	2,641	2,341
Research and development	9,742	3,558	3,997	4,001	3,995	3,521	1,129	5,862	3,500	3,334	8,848	3,307
Operating income	-40.0	6,287	5,375	7,049	5,923	6,221	8,097	4,364	6,384	6,699	-654	6,083
EBIT	-40.0	6,287	5,375	7,049	5,923	6,221	8,097	4,364	6,384	6,699	-654	6,083
EBITDA	1,428	7,691	6,793	8,147	6,987	7,279	9,211	5,510	7,450	7,618	249	7,061
Interest expense	525	479	411	327	305	313	328	330	310	303	310	317
Pre-tax income	-683	-3,534	3,420	6,745	4,999	5,903	4,170	4,090	6,006	5,670	-2,046	5,620
Income tax	654	709	458	958	571	818	426	929	545	903	-820	870
Net income	-1,335	-4,240	2,963	5,785	4,427	5,079	3,743	3,157	5,455	4,762	-1,226	4,745
Net income to common shareholders	-1,335	-4,240	2,963	5,785	4,427	5,079	3,743	3,157	5,455	4,762	-1,226	4,745
Basic EPS	-0.54	-1.72	1.19	2.32	1.76	2.01	1.48	1.25	2.15	1.88	-0.48	1.87
Diluted EPS	-0.54	-1.72	1.19	2.32	1.76	2.01	1.48	1.24	2.14	1.87	-0.48	1.86
Average shares (basic)	2,470	2,472	2,488	2,495	2,510	2,523	2,537	2,534	2,534	2,533	2,533	2,537
Average shares (diluted)	2,470	2,472	2,488	2,498	2,513	2,531	2,537	2,541	2,544	2,544	2,533	2,546
Dividend per share	0.85	0.85	0.81	0.81	0.81	0.81	0.77	0.77	0.77	0.77	0.73	0.73